EichorEICHOR
Study identifier: NCT05662202 Synced from ClinicalTrials.gov · August 05, 2026
● Completed

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Condition: Actinic Keratoses  ·  Sponsor: Biofrontera Inc.

PhasePhase 3
Planned participants172
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this study is to test the safety. tolerability and efficacy of field-directed photodynamic therapy (PDT) with 10% aminolevulinic acid gel (Ameluz®, BF-200 ALA) in combination with one of the narrow spectrum red light RhodoLED lamps in comparison to vehicle treatment for actinic keratosis (AK) on the extremities and neck/trunk.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (14)

Medical Dermatology SpecialistsPhoenix, Arizona, United States
Alliance Dermatology & Mohs CenterPhoenix, Arizona, United States
Dermatology PracticeGreenwood Village, Colorado, United States
Dermatology Associates PA of the Palm BeachesDelray Beach, Florida, United States
Gwinnett Clinical Research Center, Inc.Snellville, Georgia, United States
Laser and Skin Surgery Center of IndianaIndianapolis, Indiana, United States
The Indiana Clinical Trials Center, PCPlainfield, Indiana, United States
DelRicht ResearchBaton Rouge, Louisiana, United States
Skin Search of Rochester, Inc.Rochester, New York, United States
Rochester Dermatologic SurgeryVictor, New York, United States
Clinical Research Center of the CarolinasCharleston, South Carolina, United States
DermResearch, P.A.Austin, Texas, United States

+ 2 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →